GE HealthCare (GEHC) February 14 weekly 87 straddle priced into quarter results

Go back to GE HealthCare (GEHC) February 14 weekly 87 straddle priced into quarter results

GE HealthCare (GEHC) PT Raised to $110 at Jefferies

February 13, 2025 4:30 PM EST

Jefferies analyst Matthew Taylor raised the price target on GE HealthCare (NASDAQ: GEHC) to $110.00 (from $103.00) while maintaining a Buy rating.

The analyst comments "GEHC reported 4Q sales of $5.32B, +2% xfx (+4% ex-China) vs cons $5.32B, & EPS of $1.45 +23% vs cons $1.26. Orders... More

GE HealthCare (GEHC) PT Raised to $104 at Stifel

February 13, 2025 2:45 PM EST

Stifel analyst Rick Wise raised the price target on GE HealthCare (NASDAQ: GEHC) to $104.00 (from $102.00) while maintaining a Buy rating.

The analyst comments "Following the GEHC 4Q24 call, we came away feeling encouraged about the companys 4Q24 performance and initial 2025... More

GE HealthCare (GEHC) PT Raised to $110 at Citi

February 13, 2025 2:15 PM EST

Citi analyst Joanne Wuensch raised the price target on GE HealthCare (NASDAQ: GEHC) to $110.00 (from $103.00) while maintaining a Buy rating.

The analyst comments "There was a lot to the 4Q24 against relatively low expectations, with the top-line reflecting continued pressures in China, and... More

GE HealthCare (GEHC) PT Raised to $103 at BTIG

February 13, 2025 11:38 AM EST

BTIG analyst Ryan Zimmerman raised the price target on GE HealthCare (NASDAQ: GEHC) to $103.00 (from $99.00) while maintaining a Buy rating.

The analyst comments "We maintain our Buy and raise our PT to $103 (from $99) following GEHC's 4Q24 results. Rev. of $5.319B (2.0% Y/Y, 2.0% Y/Y organic) and adj. EPS of $1.45 (22.9% Y/Y)... More